Head-To-Head Survey: Envoy Medical (COCH) & Its Competitors

Envoy Medical (NASDAQ:COCH) is one of 51 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Envoy Medical to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for Envoy Medical and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	400	1404	2528	116	2.53

Envoy Medical currently has a consensus price target of $9.00, suggesting a potential upside of 584.93%. As a group, “Surgical appliances & supplies” companies have a potential upside of 35.34%. Given Envoy Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Envoy Medical is more favorable than its rivals.

Earnings & Valuation

This table compares Envoy Medical and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.93
Envoy Medical Competitors	$1.41 billion	$234.66 million	19.84

Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Envoy Medical has a beta of 2.35, meaning that its stock price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 1.28, meaning that their average stock price is 28% more volatile than the S&P 500.

Profitability

This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Summary

Envoy Medical rivals beat Envoy Medical on 7 of the 13 factors compared.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.